Marsh J D
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.
J Clin Invest. 1989 Sep;84(3):817-23. doi: 10.1172/JCI114241.
To examine mechanisms whereby the abundance of functional Ca channels may be regulated in excitable tissue, Ca channel number was estimated by binding of the dihydropyridine (DHP) antagonist 3H (+)PN200-110 to monolayers of intact myocytes from chick embryo ventricle. Beta adrenergic receptor properties were studied in cultured myocytes using [3H]CGP12177, an antagonist ligand. Physiological correlates for alterations in DHP binding site number included 45Ca uptake and contractile response to (+)BAYk 8644, a specific L-type Ca channel activator. All binding and physiological determinations were performed in similar intact cell preparations under identical conditions. 4-h exposure to 1 microM isoproterenol reduced cell surface beta-adrenergic receptor number from 44 +/- 3 to 17 +/- 2 fmol/mg (P less than 0.05); DHP binding sites declined in number from 113 +/- 25 to 73 +/- 30 fmol/mg (P less than 0.03). When protein kinase A was activated by a non-receptor-dependent mechanism, DHP binding declined similarly to 68% of control. Exposure to diltiazem, a Ca channel antagonist, for 18-24 h had no effect on number of DHP binding sites. After 4-h isoproterenol exposure, 45Ca uptake stimulated by BAYk 8644 declined from 3.3 +/- 0.2 nmol/mg to 2.9 +/- 0.3 nmol/mg (P less than 0.01) and BAYk 8644-stimulated increase in amplitude of contraction declined from 168 +/- 7 to 134 +/- 11% (P = 0.02). Thus, elevation of [cAMP] in myocytes is associated with a time-dependent decline in Ca channel abundance as estimated by DHP binding and a decline in physiological responses that are in part dependent on abundance of Ca channels. Binding of a directly acting Ca channel antagonist for 18-24 h does not modulate the number of DHP binding sites.
为了研究在可兴奋组织中功能性钙通道丰度可能受到调节的机制,通过二氢吡啶(DHP)拮抗剂3H(+)PN200 - 110与鸡胚心室完整心肌细胞单层的结合来估计钙通道数量。使用拮抗剂配体[3H]CGP12177在培养的心肌细胞中研究β肾上腺素能受体特性。DHP结合位点数量改变的生理相关指标包括45Ca摄取以及对特异性L型钙通道激活剂(+)BAYk 8644的收缩反应。所有结合和生理测定均在相似的完整细胞制剂中于相同条件下进行。暴露于1 microM异丙肾上腺素4小时后,细胞表面β肾上腺素能受体数量从44±3降至17±2 fmol/mg(P < 0.05);DHP结合位点数量从113±25降至73±30 fmol/mg(P < 0.03)。当蛋白激酶A通过非受体依赖性机制被激活时,DHP结合同样下降至对照的68%。暴露于钙通道拮抗剂地尔硫䓬18 - 24小时对DHP结合位点数量没有影响。在异丙肾上腺素暴露4小时后,BAYk 8644刺激的45Ca摄取从3.3±0.2 nmol/mg降至2.9±0.3 nmol/mg(P < 0.01),并且BAYk 8644刺激的收缩幅度增加从168±7降至134±11%(P = 0.02)。因此,心肌细胞中[cAMP]的升高与通过DHP结合估计的钙通道丰度随时间的下降以及部分依赖于钙通道丰度的生理反应的下降相关。直接作用的钙通道拮抗剂结合18 - 24小时不会调节DHP结合位点的数量。